IL1B and metabolic dysfunction-associated steatohepatitis: In this context, the finding that the expression of NLRP3 and inflammasome-associated cytokines (pro-IL-1β and pro-IL-18) is higher in patients with NASH compared to those with simple steatosis [176] has spurred research on this topic.